Navigation Links
Missing molecule in chemical production line discovered
Date:12/11/2013

LA JOLLA, CA-- It takes dozens of chemical reactions for a cell to make isoprenoids, a diverse class of molecules found in every type of living organism. Cholesterol, for example, an important component of the membranes of cells, is a large isoprenoid chemical. The molecule that gives oranges their citrusy smell and taste is an isoprenoid, as is the natural antimalarial drug artemisinin.

Now, researchers at the Salk Institute have discovered a missing step in the chain of reactions that some cells use to produce isoprenoids. Their findings, published December 10 in eLife, are not only an advance in basic science, but have immediate implications for how isoprenoids are produced for commercial use, says Joseph Noel, professor and director of Salk's Jack H. Skirball Center for Chemical Biology and Proteomics and a Howard Hughes Medical Institute Investigator.

"It turns out that not all organisms make these very important products in the way that we thought they did," says Noel, holder of Salk's Arthur and Julie Woodrow Chair and the senior author of the new paper.

All larger isoprenoids are derived from a common building block molecule called isopentenyl diphosphate (IPP), which can be made through two chemical pathways. Animal cells use the mevalonate pathway to make IPP, many bacterial cells use a pathway dubbed DXP, and plant cells use both. But scientists have struggled to understand how archaebacteria, and some bacteria, produce IPP. While many of these organisms lack proteins that are key to the DXP pathway, they're also missing the proteins that perform two final steps of the mevalonate pathway. Normally, these production steps involve first adding phosphate to the intermediate molecule, and then removing an atom of carbon.

In 2006, a team of scientists discovered that some bacteria had an enzyme called isopentenyl phosphate kinase (IPK), which could add phosphate to the precursor molecule only if the carbon had already been removed, suggesting that these two steps of the pathway could be reversed--first, a carbon removed, then, a phosphate added, rather than the other way around. But a protein that could remove the carbon--called a decarboxylase--hadn't been found to prove that the alternate pathway ending existed.

"We decided to go on what some might call a fishing expedition," says Noel. "We used bioinformatics to find all organisms with the IPK enzyme; suspecting that these would all also have the decarboxylase we were looking for."

The approach worked: in an unusual type of bacteria that live in hot springs, Noel and his colleagues pinpointed a decarboxylase that works in conjunction with IPK. First, the decarboxylase removes carbon, and then IPK adds a phosphate--the process, reversing the last two steps of the classic mevalonate pathway, still ends in IPP. Surprisingly, the decarboxylase was one that had been identified in the past, but researchers had assumed it worked in the classic version of the mevalonate pathway--removing a carbon only after phosphate had been added. Noel's team showed that the protein, however, only worked with the alternate ending of the mevalonate pathway.

"Organisms don't always do what we think they do," says Noel. "And now that we have discovered this decarboxylase, us and many other labs can start looking in more detail at all these organisms and figuring out which have unexpected wrinkles in this pathway."

For companies that produce isoprenoids--as a source of drugs, scents and flavor molecules--the discovery provides a new potential chemical pathway to make their products with. "Now, both the decarboxylase and the IPK can be put into organisms that are engineered to produce a molecule of interest," says Noel. "It may be that we can build an organism with both the conventional and alternate pathways."

Whether having both pathways working at once could boost production is unknown, but Noel's team is currently looking into it. They're also further probing the role of IPK in plant cells. The scientists discovered that many plants not only have every enzyme in the classic mevalonate pathway, but they also have a copy of IPK. Noel thinks the IPK may act as a control point to regulate the production of IPP.

"From a curiosity standpoint, we're learning something new about biology in looking at these systems," he says. "But this is also a case where these findings are immediately translatable to industry because of the economic value of these chemical products."


'/>"/>

Contact: Kat Kearney
kkearney@salk.edu
619-296-8455
Salk Institute
Source:Eurekalert

Related biology news :

1. Researchers discover first gene linked to missing spleen in newborns
2. What we know and dont know about Earths missing biodiversity
3. UCLA researchers discover missing link between stem cells and immune system
4. Missing link discovered in the defence mechanism of the tuberculosis pathogen
5. Microbial missing link discovered after man impales hand on tree branch
6. Missing polar weather systems could impact climate predictions
7. Monell scientists help identify a missing link in taste perception
8. Strange phallus-shaped creature provides crucial missing link
9. Researchers discover a missing link in signals contributing to neurodegeneration
10. Fear factor: Missing brain enzyme leads to abnormal levels of fear in mice, reveals new research
11. Study finds missing piece of pediatric cancer puzzle
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/3/2017)... WASHINGTON , Feb. 3, 2017 A ... Identity Strategy Partners, LLP (IdSP) . Designed to ... in the complex identity market, founding partners Mark ... nearly 35 combined years just in identity expertise that ... tank and non-profit leadership. The Crego-Kephart combined expertise has ...
(Date:2/2/2017)... -- Central to its deep commitment to honor the ... Prize Foundation today announced the laureates of the ... in their respective fields of Life Sciences and ... recognized with the 2017 Japan Prize for original ... the advancement of science and technology, but also ...
(Date:1/30/2017)... 2017   Invitae Corporation (NYSE: ... companies, today announced that it will report its fourth ... guidance on Monday, February 13, 2017, and Invitae,s management ... 4:45 p.m. Eastern / 1:45 p.m. Pacific. ... review financial results, guidance, and recent developments and will ...
Breaking Biology News(10 mins):
(Date:2/17/2017)... According to a new ... Service), Type (Safety, Efficacy, Validation), Disease Indication (Cancer, ... Development, Disease-Risk) - Global Forecast to 2021" published ... USD 53.34 Billion by 2021 from USD 27.95 ... 13.8% during the forecast period (2016-2021). ...
(Date:2/17/2017)... Feb. 17, 2017  Protagonist Therapeutics, Inc. (NASDAQ: ... its oral peptide drug candidates, PTG-100 and PTG-200, ... European Crohn,s and Colitis Organization (ECCO).  The ECCO ... Spain from February 15 – 18, ... data on Protagonist drug candidates PTG-100 and PTG-200. ...
(Date:2/16/2017)... Calif. and GREENWICH, Conn. ... a private investment firm focused on venture growth ... the promotion of Josh Richardson , M.D. ... on investments in biotechnology companies.  He is a ... played important roles in Longitude,s investments in Aimmune ...
(Date:2/16/2017)... , Feb. 16, 2017   Capricor Therapeutics, ... clinical-stage biotechnology company developing first-in-class biological therapies for ... it has elected to terminate its license agreement ... receptor agonists, including Cenderitide. "Our decision ... as we prioritize our efforts to advance our ...
Breaking Biology Technology: